Linvas Tablet
Marketer
Lupin Ltd
Salt Composition
Saroglitazar (4mg)
Overview Linvas Tablet
Linvas Tablets treat Non-alcoholic Steatohepatitis (NASH) without cirrhosis, Non-alcoholic Fatty Liver Disease (NAFLD) accompanied by conditions such as obesity, type 2 diabetes, high cholesterol (dyslipidemia), or metabolic syndrome, and high cholesterol in diabetic patients. For optimal results, take Linvas Tablets daily at the same time, with or without food, and continue unless your physician instructs otherwise. Adherence to your doctor's prescribed diet and exercise plan is crucial. Maintaining a healthy weight through lifestyle changes significantly supports liver health. Common, generally mild, side effects include gas, indigestion, abdominal bloating, fever, and fatigue. Report any persistent or concerning side effects to your doctor. Before starting Linvas Tablets, inform your doctor of any history of kidney, heart, or pancreatic issues, excessive alcohol consumption, or pregnancy/breastfeeding. Disclose all other medications you're taking, as interactions may occur. Reduce alcohol intake while using this medication to protect your liver. Regular monitoring of liver and kidney function, along with blood glucose levels, will assess the medication's effectiveness.
Uses of Linvas Tablet
Managing Nonalcoholic Steatohepatitis (NASH) without cirrhosis | Addressing Nonalcoholic Fatty Liver Disease (NAFLD) | Diabetic hyperlipidemia management (high cholesterol in diabetes)
Major Benefits of Linvas Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the tablet whole; avoid crushing, chewing, or breaking it. Linvas Tablet can be administered with or without food, however, consistent timing is recommended.
Common Side effects of Linvas Tablet:
- Flatulence
- Indigestion
- Abdominal distension
- Weakness
- Increased body temperature
How to use Linvas Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the tablet whole; avoid chewing, crushing, or breaking it. Linvas Tablet can be administered with or without food, however, consistent timing is recommended.
How Linvas Tablet works:
Saroglitazar, the active component of Linvas Tablet, is a dual peroxisome proliferator-activated receptor (PPAR) antagonist. This medication assists in managing elevated cholesterol, particularly triglyceride levels, and blood glucose in patients with type 2 diabetes. Its novel mechanism of action involves suppressing triglyceride (a blood lipid) production and release. Concurrently, it enhances insulin sensitivity, improving the body's use of insulin and thereby reducing blood sugar.
SAFETY ADVICE
AlcoholUNSAFE
Avoid alcohol consumption while taking Linvas Tablets.
PregnancyCONSULT YOUR DOCTOR
The use of Linvas Tablet during pregnancy may pose risks. While human data is scarce, animal studies indicate potential harm to a developing fetus. A physician will assess the advantages against possible dangers prior to prescribing. Seek medical advice.
Breast feedingCAUTION
Mothers who are breastfeeding should exercise caution when taking Linvas Tablets. Breastfeeding is advised against until the mother's course of treatment concludes and the medication is fully cleared from her system.
DrivingSAFE
Driving ability is typically unaffected by Linvas Tablet.
KidneyCONSULT YOUR DOCTOR
Data regarding Linvas Tablet use in patients with renal impairment is scarce. Physician consultation is advised.
LiverCONSULT YOUR DOCTOR
Insufficient data exists regarding Linvas Tablet's use in individuals with hepatic impairment. Physician consultation is advised.
What if you forget to take Linvas Tablet :
Take a missed dose as soon as you remember. However, if your next dose is nearly due, omit the missed one and continue with your regular schedule. Never take a double dose.
Facts to Know About Linvas Tablet
| Label | Value |
|---|---|
| Chemical Type | Phenylpyrrole analog |
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
| Action Class | PPARα/γ dual agonist |
3,018 People bought this recently
